Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,334,000 | 12,266,000 | 12,949,000 | 10,576,000 | 11,053,000 |
| Depreciation Amortization | 2,939,000 | 2,774,000 | 2,832,000 | 2,777,000 | 2,177,000 |
| Income taxes - deferred | 356,000 | -436,000 | 22,000 | -1,762,000 | -1,168,000 |
| Accounts receivable | -195,000 | 511,000 | -650,000 | -394,000 | -713,000 |
| Other Working Capital | -858,000 | 1,339,000 | -1,639,000 | 1,248,000 | 968,000 |
| Other Operating Activity | 809,000 | 117,000 | 1,458,000 | 2,577,000 | 1,931,000 |
| Operating Cash Flow | $16,385,000 | $16,571,000 | $14,972,000 | $15,022,000 | $14,248,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,860,000 | -2,211,000 | -2,281,000 | -2,485,000 | -2,155,000 |
| Net Acquisitions | -1,269,000 | -2,470,000 | -1,214,000 | -1,388,000 | -18,023,000 |
| Purchase Of Investment | -15,788,000 | -10,040,000 | -3,668,000 | -9,659,000 | -467,000 |
| Sale Of Investment | 11,101,000 | 7,232,000 | 3,059,000 | 7,988,000 | 426,000 |
| Other Investing Activity | -38,000 | -109,000 | -83,000 | -368,000 | -72,000 |
| Investing Cash Flow | $-7,854,000 | $-7,598,000 | $-4,187,000 | $-5,912,000 | $-20,291,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,874,000 | 9,484,000 | 8,430,000 | 19,626,000 | 6,385,000 |
| Debt Issued | 1,118,000 | 9,000 | 1,638,000 | 5,100,000 | 6,000 |
| Debt Repayment | -32,000 | -219,000 | -24,000 | -18,000 | -13,000 |
| Common Stock Issued | 1,226,000 | 882,000 | 1,486,000 | 1,562,000 | 1,135,000 |
| Common Stock Repurchased | -2,797,000 | -2,130,000 | -6,651,000 | -5,607,000 | -6,722,000 |
| Dividend Paid | -5,804,000 | -5,327,000 | -5,024,000 | -4,670,000 | -4,267,000 |
| Other Financing Activity | -6,565,000 | -6,791,000 | -7,319,000 | -21,691,000 | -2,633,000 |
| Financing Cash Flow | $-4,980,000 | $-4,092,000 | $-7,464,000 | $-5,698,000 | $-6,109,000 |
| Exchange Rate Effect | -6,000 | 161,000 | -323,000 | 275,000 | 180,000 |
| Beginning Cash Position | 15,810,000 | 10,768,000 | 7,770,000 | 4,083,000 | 16,055,000 |
| End Cash Position | 19,355,000 | 15,810,000 | 10,768,000 | 7,770,000 | 4,083,000 |
| Net Cash Flow | $3,545,000 | $5,042,000 | $2,998,000 | $3,687,000 | $-11,972,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,385,000 | 16,571,000 | 14,972,000 | 15,022,000 | 14,248,000 |
| Capital Expenditure | -2,384,000 | -2,365,000 | -3,066,000 | -2,942,000 | -2,666,000 |
| Free Cash Flow | 14,001,000 | 14,206,000 | 11,906,000 | 12,080,000 | 11,582,000 |